OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Marillac Neurological Care Centre Annual Report and Financial Statements

31 March 2024

Charity Registration Number 1184495 Company Limited by Guarantee Registration Number 12085591 (England and Wales)

Contents

Reports

Reports
Reference and administrative details of
the charitable company, its
trustees and advisers 1
Trustees’ report 3
Independent auditor’s report 15
Financial Statements
Statement of financial activities 20
Balance sheet 21
Statement of cash flows 22
Principal accounting policies 23
Notes to the financial statements 27

Marillac Neurological Care Centre

Reference and administrative details of the charitable company, its trustees and advisers

Trustees Peter Nicol
Sister Kathleen Fox
Ian Restall (resigned 3 July 2024)
Barry Hawkins
Dr Michael Apps
Sister Mary Timmons
Sean O Hare (appointed 1 July 2024)
Clive Edwards (appointed 1 July 2024)
Rev Abraham Lawrence (resigned 11 April
2024)
Company Secretary and Director of Finance Catherine Woodhead (resigned 26 November
2023)
CEO Beverley Hill
Director of Nursing Paul Dixon
Director of Therapies Precious Mazengera
Director of Governance Tess Essop
Director of Admissions and Marketing Suzana Scheele De Moraes
Lyndsay Vincent
Registered Office Eagle Way
Warley
Brentwood
Essex
CM13 3BL
Telephone 01277 220276
Facsimile 01277 204060
Web site www.marillac.co.uk

Marillac Neurological Care Centre 1

Reference and administrative details of the charitable company, its trustees and advisers

Company Registration Number 12085591 (England and Wales) Charity Registration Number 1184495 Auditor Buzzacott LLP 130 Wood Street London EC2V 6DL Principal Bankers HSBC 91 High Street Brentwood Essex CM14 4RU

Marillac Neurological Care Centre 2

Trustees’ report Year ended 31 March 2024

The trustees present their report together with the financial statements of Marillac Neurological Care Centre (MNCC) for the year ended 31 March 2024. The report has been prepared in accordance with Part 8 of the Charities Act 2011 and constitutes a directors’ report for the purposes of company legislation.

The financial statements have been prepared in accordance with the accounting policies set out on pages 23 to 26 and comply with the charitable company’s memorandum and articles of association, applicable laws and applicable Financial Reporting Standards (United Kingdom Generally Accepted Accounting Practice), including Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102).

Constitution and background

MNCC was incorporated on 4 July 2019 and is a company limited by guarantee (Company Registration No. 12085591 (England and Wales)) and a registered charity (Charity Registration No. 1184495). The charitable company is governed by its memorandum and articles of association.

DCSVP Services is the sole member of the charitable company, and thus its parent entity. DCSVP Services is a registered charity (Charity Registration Number 1149326) and a company limited by guarantee (Company Registration Number 07638065 (England and Wales)), set up by the Daughters of Charity of St Vincent de Paul (the Daughters) to safeguard the Vincentian ethos in various projects such as Marillac Neurological Care Centre.

Until midnight on 31 March 2021, Marillac Neurological Care Centre was part of a registered charity - Daughters of Charity of St Vincent de Paul Charitable Trust, Charity Registration Number 236803 (England and Wales) and Charity Registration Number SCO39155 (Scotland).

On 1 April 2021, in accordance with a legal transfer of undertakings agreement, the activities, assets and liabilities of MNCC were transferred as a going concern to Marillac Neurological Care Centre. As part of the transfer, the trustees of the Daughters of Charity of St Vincent de Paul Charitable Trust agreed to transfer an additional £600,000 of that charity’s funds to the new charitable company to ensure that it commenced activity with free reserves in line with its reserves policy.

Objectives and aims

Marillac Neurological Care Centre, based in Brentwood, Essex, provides a fifty-two place Care Centre called The Marillac, which is registered with the Care Quality Commission (CQC) for the provision of nursing and personal care and the treatment of disease, disorder or injury.

Marillac Neurological Care Centre 3

Trustees’ report Year ended 31 March 2024

We provide services to adults with acquired brain injury, degenerative neurological disorders and complex physical disabilities. We have three units comprising two 16 bed units and a third unit comprising 17 beds and three bungalows. All three units provide specialist nursing and rehabilitation services to clients with neuro based long term conditions including traumatic and hypoxic brain injury and chronic medical conditions such as multiple sclerosis and motor neurone disease and other neuro based conditions presenting as complex care.

Our mission

Our aim is to provide a centre of excellence for adults with neurological and complex physical disabilities and to provide care that is:

In formulating these aims, the trustees and management have given careful consideration to the Charity Commission’s general guidance on public benefit.

Progress during the year

Covid-19

MNCC has now closed the COVID response team having successfully navigated the pandemic with no loss of life. Systems of work were reviewed, and new methods and systems now fully implemented.

Development of facilities

Our facilities have been improved by investment and management.

Our Estates Department has implemented a process of repair or replacement for items of risk and has ensured that the estate is fit for purpose. We have taken a pro-active approach and have launched two major initiatives during 2023. Courtesy of a large donation we were in the position to install air conditioning into resident rooms and communal areas. During the planning phase we became aware that the current Electricity supply was not powerful enough and had very little spare capacity for this or any future electrical need. Our landlords, kindly donated the majority of the costs to upgrade this allowing MNCC to future proof its electrical needs and allow the original project to continue. The estates team Project managed the Electrical upgrade and Air conditioning project with skill ensuring that both were being delivered within cost and with no impact on the residents.

Marillac Neurological Care Centre 4

Trustees’ report Year ended 31 March 2024

In the past 12 months the Estates Team have worked tirelessly to ensure that the site looks fit for purpose externally as well as internally. A large amount of work is present in the preparation of rooms for each new resident with every room decorated and deep cleaned before every admission. We have a roll out of new smart TV’s in all resident rooms.

A rolling programme of redecoration and refurbishment has been implemented as has essential ground maintenance which includes tree removal, as necessary. Internal decoration has lifted the communal areas to a bright and vibrant area.

Other areas of investment include another 20% flat roof replacement, St Catherines bedroom furniture replacement, radiator valve replacement and fire stopping.

Courtesy of a generous donation (Matchroom Charitable Foundation) we were able to install an emergency generator for MNCC which will protect our residents but also allow us to expand our service offering to those who require mechanical assistance (e.g. ventilator) to maintain life.

Development of services

Our services have an outstanding reputation within the Healthcare community which has led to very high occupancy levels of 96.2% compared to the NHS occupancy of 92.6% (Nuffield Trust: https://www.nuffieldtrust.org.uk/resource/chart-of-the-week-are-a-greater-proportionof-nhs-hospital-beds-being-occupied-this-winter). National Institute for Health and Care Excellence (NICE) suggested in 2018 a “pragmatic maximum” of 90% whilst the 2023/2024 NHS operational planning guidance recommended that bed occupancy should not exceed 92%.

The complexity of our services is recognised by our purchasers as being extremely high. At one point we had more people using enteral feeding than the local NHS Trust.

Our services continue to develop in line with service need. We analyse our referrals and conduct a paper review on all referrals. We host a bed management meeting with all clinical parties represented to ensure that we are meeting the needs of the patients that are referred.

Our services, in discussion with our purchasers, continue to provide the services required by the NHS. When we have received feedback one comment received was to expand the service. All feedback that we received has been reviewed and where possible implemented.

Regular verbal feedback is gathered via Director of Admissions, and this is fed back to the Senior Team and Board within regular reporting structures.

There has been no major change to service provision as identified needs of both residents and commissioners remains stable.

MNCC has and will continue to regularly monitor the marketplace for any changes in commissioning intentions and will highlight any areas of suggested development will be made to the Board of Trustees.

Marillac Neurological Care Centre 5

Trustees’ report Year ended 31 March 2024

Development of staff

In order to provide a high level of care to our residents, we recognise that our staff are vital. We strive hard to recognise and reward the hard work undertaken, often in stressful and emotional situations.

We provide a free employee assistance program for all employees and access to Occupational Health and psychology.

We also actively encourage training and development of all employees who are able to attend additional funded training in many areas on top of their mandatory training. We are currently sponsoring 7 employees on Nursing/Care apprenticeships as well as 2 on a management apprenticeship and 1 on an MBA course.

During the year, we were able to provide a significant pay rise for staff of 5% and 20% to our daytime Qualified Clinical staff.

We endeavour to benchmark our salaries across the sector to ensure that we are paying an industry norm or over, for example, one benefit is that we offer all staff a paid break which equates to an extra 2.5 hours payment each week (FTE)

Quality of care

MNCC has four sub-groups to the Board of Trustees - all have Trustee and SMT representation. The sub-groups are Finance, Clinical, Audit and Fundraising. Each is led by a trustee with a Senior manager present to support. The CEO attends all subgroups as an attendee.

The Audit group conducts audits on all areas and specifically reviews and structures the audits received from the clinical groups looking at any trends and feeding this back to the Board.

The Finance group scrutinises the monthly accounts and advises the Board of any areas of concern. The group has delegated authority as per a scheme of delegation to authorise spends.

The Clinical group scrutinises all accident and incident forms and discusses any themes. These are pertinent to the quality of care that we provide. We also review all safeguarding incidents and review the action plans of any concerns that have been identified. This ensures that we are being proactive in learning lessons and sharing areas of concern with all clinical colleagues.

Our quality of care has been subject to the same concern faced by the NHS, Independent and Charity Healthcare providers regarding the shortage of staff. Our staffing manager has worked tirelessly to ensure that safe staffing levels are maintained which is credit to the whole staff group that they have ensured the unit has been maintained.

Fundraising group has been developed to lead on and advise the board on the fundraising strategy including the recruitment of a Fundraising and Partnerships manager.

Marillac Neurological Care Centre 6

Trustees’ report Year ended 31 March 2024

Safeguarding

We have experienced seven safeguarding alerts (a reduction from 2022-23) which have all been investigated and our investigations have been submitted to the Local Authority (LA). Of these, one (that we raised against ourselves) was substantiated and one partially substantiated the other 5 were closed with no further action.

The safeguarding alerts are serious events that have led us or other providers to raise concerns. We have completed our lessons learned where required and shared best practice guidelines with all services where needed.

Three safeguarding alerts have been substantiated with all lessons learned and actions implemented. These safeguards have all been raised in our clinical governance committee to ensure that lessons are cascaded.

Inspections

MNCC has received no follow up inspection from the CQC and unfortunately retains its rating of requires improvement. There is currently no route for MNCC to request a re inspection from CQC.

Vincentian Values training

Our online system to Vincentian Values training which requires all new staff to complete within 6 months of appointment has proved to be an effective method of training and has ensured that people are aware of our history.

Pastoral care

Our Pastoral Lead who started in 2022, Sister Rosalie has been developed relationships with staff, families and residents. Attending family events and co-ordinating any pastoral needs

The way forward

Marillac Neurological Care Centre has experienced another positive year commercially and reputationally. Our relationships with our commissioners remain strong.

Our occupancy remains strong and communication with purchasers indicates that we are providing the service that is needed in the healthcare environment. We will continue to monitor our position carefully to ensure that if the market forces begin to alter then we have addressed our service offering accordingly.

Our governance has become stronger and our trustee involvement in our monthly governance meetings has ensured that we as the provider are operating with honesty and integrity.

Marillac Neurological Care Centre 7

Trustees’ report Year ended 31 March 2024

Financial report for the year

A summary of the year’s results can be found on page 20 of the attached financial statements.

In the year to 31 March 2024 income amounted to £7,962,666 (2023: £6,638,242. Expenditure for the year amounted to £7,139,414 (2023: £6,591,057).

Occupancy in the year remained high at 96.2%.

Reserves and financial position

The trustees and Senior Management Team of Marillac Neurological Care Centre have examined the requirement for free reserves i.e. those unrestricted funds not invested in tangible fixed assets, or otherwise committed. The trustees and Senior Management Team consider that, given the nature of the work undertaken at Marillac Neurological Care Centre, the level of free reserves should be equal to between 3 and 6 months’ recurring expenditure.

The trustees and Senior Management Team are of the opinion that this level of reserves should provide sufficient flexibility to cover temporary shortfalls in income due, for example, to falls in occupancy levels.

Total funds at 31 March 2024 amounted to £3,020,361 (2023: £2,197,109).

The tangible fixed assets fund of £1,472,661 (2023: £565,308) represents the net book value of Marillac Neurological Care Centre’s tangible fixed assets in respect to furniture and equipment. The assets are used in the day-to-day work and would not be realisable in order to meet expenditure and future contingencies.

Restricted funds comprise monies given for specific purposes and amounted to £22,915 (2023: £39,920) at 31 March 2024.

General funds, or free reserves, at 31 March 2024 totalled £1,524,785 (2023: £1,591,881) representing 2.56 months of recurring expenditure and hence were outside the reserves policy.

The financial position of MNCC at 31 March 2024 means that the trustees of MNCC are of the view that it will have sufficient resources to enable it to remain a going concern despite the continuing challenges caused by the current macroeconomic climate.

Custodian funds

As at 31 March 2024 Marillac Neurological Care Centre held funds on behalf of residents totalling £7,109 (2023: £12,636) as Custodian Trustee. The funds are held in a bank account separate from Marillac Neurological Care Centre’s own funds. The funds are not included in these financial statements and they are segregated clearly from those belonging to Marillac Neurological Care Centre itself at all times.

Marillac Neurological Care Centre 8

Trustees’ report Year ended 31 March 2024

Trustees

The trustees constitute directors of the charitable company for the purposes of company legislation. The trustees in office at the time of approval of this report are:

Peter Nicol Sister Kathleen Fox Barry Hawkins Sister Mary Timmons Dr Michael Apps Sean O’Hare Clive Edwards

Our recruitment of trustees is multi-faceted. We engage social media, Linkedin and indeed to name two, our own website, word of mouth and recommendation. We have received 4 applications in the year ending 2024 and have shortlisted all 4. Our induction process includes orientation to the service, policy and procedure access, meeting with key personnel and safeguarding training. Following receipt of a DBS Trustees can attend meetings on site.

Governance and organisation

A range of governance and management committees, including the Senior Management Team, Heads of Departments, and Health and Safety Committee are in place to ensure effective leadership and governance of the organisation and its activities. An Annual Development Plan summarises key development objectives for each department within Marillac Neurological Care Centre.

Marillac Neurological Care Centre has 3 units, in which 52 residents live. Residents’ care is organised through an established nursing structure of qualified registered nurses, led by a unit nurse manager and co-ordinated by staff nurses. The registered nurses have appropriate training, and they are supported by a team of health care support workers and care assistants who provide personal care and attention to the residents. There is a multi-disciplinary therapy department which includes occupational therapists, speech and language therapists and physiotherapists. The clinical and therapy teams work very closely together, enhancing and striving to maintain residents’ optimum potential, through coordinating a range of therapeutic activities, exercise or positioning by improving seating, coordinating speech therapy and other therapies as required. Social care is provided by lifestyle and activity coordinators who work closely with the nursing and therapy team.

Key management personnel

The trustees consider that they, together with the CEO, Director of Finance, Director of Nursing, Director of Therapies, Director of Governance and Director of Admissions and Marketing comprise the key management of the charitable company in charge of directing and controlling, running and operating the charitable company on a day-to-day basis.

The remuneration of key management personnel is set by the trustees in conjunction with a consultancy firm, having regard to industry benchmarks.

Marillac Neurological Care Centre 9

Trustees’ report Year ended 31 March 2024

Statement of trustees’ responsibilities

The trustees (who are also directors for the purposes of company law) are responsible for preparing the Annual Report and Financial Statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the income and expenditure of the charitable company for that year.

In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Each of the trustees confirms that:

This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies Act 2006.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Marillac Neurological Care Centre 10

Trustees’ report Year ended 31 March 2024

Risk management

In line with the requirement for the trustees to undertake a risk assessment exercise and report on the same in their annual report, the Senior Management Team has looked at the risks Marillac Neurological Care Centre currently faces and has reviewed the measures already in place, or needing to be put in place, to deal with them. We have identified five main areas where risk may occur:

Governance and Management covers the risk of Marillac Neurological Care Centre suffering from a lack of direction, management capacity and capability, risk management and governance arrangements.

Operational looks at the risk inherent in Marillac Neurological Care Centre’s activities including staffing, training, relevant expertise, equipment, building suitability and poor maintenance, shortcomings in the services provided etc.

Health and Safety risks include fire, accidents, inadequately maintained equipment, security, food hygiene and substances hazardous to health.

Financial risks include those arising as a result of poor budgetary control, insufficient referrals, inability to secure appropriate charges, poor accounting, inappropriate investment policies, financial risks from the development of new services, and changes to the commissioning process with the introduction of NHS England commissioning via Clinical Commissioning Groups.

Environmental, Regulatory and Reputational Factors cover failure to comply with regulatory requirements, adverse external events, and failure to keep up with changes in legislation, changes in the way services are commissioned from us, and possible damage to Marillac Neurological Care Centre’s reputation.

Having assessed the major risks to which Marillac Neurological Care Centre is exposed, the Senior Management Team believes that by monitoring reserve levels, by ensuring controls exist over key financial systems, and by examining the operational and business risks faced by Marillac Neurological Care Centre, it has in place systems to manage those risks.

Marillac Neurological Care Centre 11

Trustees’ report Year ended 31 March 2024

Key risks:

Marillac Neurological Care Centre 12

Trustees’ report Year ended 31 March 2024

Fundraising policy

MNCC aims to achieve best practice in the way in which it communicates with donors and other supporters. It takes care with both the tone of its communications and the accuracy of its data to minimise the pressures on supporters. It applies best practice to protect supporters’ data and never sells data, it never swaps data and ensures that communication preferences can be changed at any time.

MNCC has taken the decision to commence formal fundraising on the back of a successful informal approach to a local business which gained a substantial donation. It has followed this up with a further approach and has been informed this too will be successful. MNCC has instigated a fundraising group to formalise our approach and look into the feasibility of employing a part time fundraising and partnerships manager to lead on all fundraising activities.

MNCC undertakes to react to and investigate any complaints regarding its fundraising activities and to learn from them and improve its service. During 2024, MNCC received no complaints about its fundraising activities (2023: none).

Volunteers

Marillac Neurological Care Centre believes in enhancing the lives of our residents. In order to provide as much enhancement as possible we make use of volunteers for various activities.

Employees

Marillac Neurological Care Centre strives to be an equal opportunities employer and applies objective criteria to assess merit. It aims to ensure that no job applicant or employee receives less favourable treatment on the grounds of age, race, colour, nationality, religion, ethnic or national origin, gender, marital status, sexual orientation or disability.

Marillac Neurological Care Centre 13

Trustees’ report Year ended 31 March 2024

Our thanks

We express our thanks:

The trustees’ report, which constitutes a directors’ report for the purposes of company legislation, has been prepared in accordance with the special provisions applicable to companies subject to the small companies’ regime.

Approved by:

Peter Nicol

Date of approval: 20 November 2024

Marillac Neurological Care Centre 14

Independent auditor’s report Year ended 31 March 2024

Independent auditor’s report to the member of Marillac Neurological Care Centre

Opinion

We have audited the financial statements of Marillac Neurological Care Centre for the year ended 31 March 2024, which comprise the statement of financial activities, the balance sheet, the statement of cash flows, the principal accounting policies and the notes to the financial statements. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of financial statements section of our report. We are independent of the foundation in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the ability of Marillac Neurological Care Centre to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Marillac Neurological Care Centre 15

Independent auditor’s report Year ended 31 March 2024

Other information

The other information comprises the information included in the Annual Report, including the trustees’ report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report. we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Marillac Neurological Care Centre 16

Independent auditor’s report Year ended 31 March 2024

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement, set out on page 10, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

In identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

Marillac Neurological Care Centre 17

Independent auditor’s report Year ended 31 March 2024

Auditor’s responsibilities for the audit of the financial statements (continued)

We assessed the susceptibility of the charitable company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Marillac Neurological Care Centre 18

Independent auditor’s report Year ended 31 March 2024

Use of our report

This report is made solely to the charitable company’s member, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s member those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s member, as a body, for our audit work, for this report, or for the opinions we have formed.

Peter Mackereth (Senior Statutory Auditor) For and on behalf of Buzzacott LLP, Statutory Auditor 130 Wood Street London EC2V 6DL

21 November 2024

Marillac Neurological Care Centre 19

Statement of financial activities (including income and expenditure account) Year ended 31 March 2024

Notes Un-
restricted
funds
£		 Restricted
funds
£
Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£
Total
funds
2023
£
Income from:
Donations and Legacies
1
Interest receivable
Charitable activities
. Fees and related charges
Other sources
2
Total income
Expenditure on:
Charitable activities
. Nursing care and related services
3
Total expenditure
Net income and net movement in
funds
6
Transfer between funds
Reconciliation of funds:
Balances brought forward
at 1 April 2023
Balances carried forward
at 31 March 2024		 264,341
29,131
6,842,213
205,568
621,413

—

—

—

885,754
29,131

6,842,213
205,568		 13,083
5,798
6,360,532
188,474
70,355

—

—

—
83,438

5,798

6,360,532

188,474
7,341,253
621,413
7,962,666		 6,567,887
70,355
6,638,242
7,099,907
39,507



7,139,414		 6,558,427
32,630
6,591,057
7,099,907
39,507
7,139,414		 6,558,427
32,630
6,591,057
241,346
598,911
2,157,189		 581,906

(598,911)

39,920

823,252


—




2,197,109		 9,460
19,200

2,128,529		 37,725

(19,200)

21,395
47,185

—

2,149,924
2,997,446
22,915


3,020,361		 2,157,189
39,920
2,197,109

All activities derived from continuing operations.

All recognised gains and losses are included in the above statement of financial activities.

Marillac Neurological Care Centre 20

Balance sheet 31 March 2024

Notes 2024
£		 2024
£		 2023
£		 2023
£
Fixed assets
Tangible assets
9
Current assets
Debtors
10
Cash at bank and in hand
Creditors: amounts falling due
within one year
11
Net current assets
Total net assets
Represented by:
Funds
Restricted funds
12
Unrestricted funds
. Tangible fixed assets fund
13
. General fund		 815,866
1,094,675		 1,472,661
1,547,700		 670,473
1,243,416		 565,308
1,631,801
1,910,541
(362,841)		 1,913,889
(282,088)
1,472,661
1,524,785		 565,308
1,591,881
3,020,361 2,197,109
22,915
2,997,446		 39,920
2,157,189
3,020,361 2,197,109

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime.

Approved by the trustees and signed on their behalf by:

Peter Nicol

Trustee

Date of approval: 20 November 2024

Registered Company Number: 12085591 (England and Wales)

Marillac Neurological Care Centre 21

Statement of cash flows Year ended 31 March 2024

Notes
2024
£		 2023
£
Cash flows from operating activities:
Net cash (used in) provided by operating activities
A
Cash flows from investing activities:
Interest received
Purchase of tangible fixed assets

Net cash used in investing activities

Change in cash and cash equivalents in the year
Cash and cash equivalents at 1 April 2023
B
Cash and cash equivalents at 31 March 2024
B

869,486		 (8,035)


29,131
**(1,047,358) **		 5,798
(187,800)
**(1,018,227) ** (182,002)

(148,741)


1,243,416
 (190,037)
1,433,453

1,094,675		 1,243,416

Notes to the statement of cash flows for the year to 31 March 2024.

A
B
C		 Reconciliation of net movement in funds to net cash (used in) provided by operating
activities
2024
£
2023
£
Net movement in funds (as per the statement of financial activities)
823,252
47,185
Adjustments for:
Depreciation charge
140,005
144,751
Interest receivable
(29,131)
(5,798)
(Increase) in debtors
(145,393)
(106,785)
Increase/(decrease) in creditors
80,753
(87,388)
Net cash(used in) provided by operating activities
869,486
(8,035)
Analysis of cash and cash equivalents
2024
£
2023
£
Total cash and cash equivalents: Cash at bank and in hand
1,094,675
1,243,416
Analysis of changes in net debt
At
1 April
2023
£
Cash flows
£
At 31
March
2024
£
Cash
1,243,416
(148,741)
1,094,675
Total
1,243,416
(148,741)
1,094,675		 Reconciliation of net movement in funds to net cash (used in) provided by operating
activities
2024
£
2023
£
Net movement in funds (as per the statement of financial activities)
823,252
47,185
Adjustments for:
Depreciation charge
140,005
144,751
Interest receivable
(29,131)
(5,798)
(Increase) in debtors
(145,393)
(106,785)
Increase/(decrease) in creditors
80,753
(87,388)
Net cash(used in) provided by operating activities
869,486
(8,035)
Analysis of cash and cash equivalents
2024
£
2023
£
Total cash and cash equivalents: Cash at bank and in hand
1,094,675
1,243,416
Analysis of changes in net debt
At
1 April
2023
£
Cash flows
£
At 31
March
2024
£
Cash
1,243,416
(148,741)
1,094,675
Total
1,243,416
(148,741)
1,094,675		 Reconciliation of net movement in funds to net cash (used in) provided by operating
activities
2024
£
2023
£
Net movement in funds (as per the statement of financial activities)
823,252
47,185
Adjustments for:
Depreciation charge
140,005
144,751
Interest receivable
(29,131)
(5,798)
(Increase) in debtors
(145,393)
(106,785)
Increase/(decrease) in creditors
80,753
(87,388)
Net cash(used in) provided by operating activities
869,486
(8,035)
Analysis of cash and cash equivalents
2024
£
2023
£
Total cash and cash equivalents: Cash at bank and in hand
1,094,675
1,243,416
Analysis of changes in net debt
At
1 April
2023
£
Cash flows
£
At 31
March
2024
£
Cash
1,243,416
(148,741)
1,094,675
Total
1,243,416
(148,741)
1,094,675		 Reconciliation of net movement in funds to net cash (used in) provided by operating
activities
2024
£
2023
£
Net movement in funds (as per the statement of financial activities)
823,252
47,185
Adjustments for:
Depreciation charge
140,005
144,751
Interest receivable
(29,131)
(5,798)
(Increase) in debtors
(145,393)
(106,785)
Increase/(decrease) in creditors
80,753
(87,388)
Net cash(used in) provided by operating activities
869,486
(8,035)
Analysis of cash and cash equivalents
2024
£
2023
£
Total cash and cash equivalents: Cash at bank and in hand
1,094,675
1,243,416
Analysis of changes in net debt
At
1 April
2023
£
Cash flows
£
At 31
March
2024
£
Cash
1,243,416
(148,741)
1,094,675
Total
1,243,416
(148,741)
1,094,675
Net movement in funds (as per the statement of financial activities)
Adjustments for:
Depreciation charge
Interest receivable
(Increase) in debtors
Increase/(decrease) in creditors
Net cash(used in) provided by operating activities		 823,252
140,005
(29,131)
(145,393)
80,753		 47,185
144,751
(5,798)
(106,785)
(87,388)
869,486 (8,035)
Analysis of cash and cash equivalents
Total cash and cash equivalents: Cash at bank and in hand		 2024
£
1,094,675
Cash flows
£
(148,741)
(148,741)		 2023
£
1,243,416
At 31
March
2024
£
1,094,675
1,094,675
Analysis of changes in net debt At
1 April
2023
£
Cash
Total		 1,243,416
1,243,416

Marillac Neurological Care Centre 22

Principal accounting policies Year ended 31 March 2024

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements of Marillac Neurological Care Centre are laid out below.

Basis of preparation

These financial statements have been prepared for the year to 31 March 2024 with comparative information provided in respect to the year to 31 March 2023.

The financial statements have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant accounting policies below or the notes to these financial statements.

The financial statements have been prepared in accordance with the principles set out in Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (Charities SORP FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The charity constitutes a public benefit entity as defined by FRS 102.

The financial statements are presented in sterling and are rounded to the nearest pound.

Marillac Neurological Care Centre is a private company limited by guarantee, incorporated in England and Wales. Its registered office address is Eagle Way, Warley, Brentwood, Essex, CM13 3BL. Marillac Neurological Care Centre, based in Brentwood, Essex, provides a fifty-two place Care Centre called The Marillac, which is registered with the Care Quality Commission (CQC) for the provision of nursing and personal care and the treatment of disease, disorder or injury.

Critical accounting estimates and areas of judgement

Preparation of the financial statements requires the trustees and management to make significant judgements and estimates.

The main judgements and estimates applied in these financial statements relate to the estimation of the useful economic life of tangible fixed assets for the purpose of determining an annual depreciation charge; the assessment of any bad or doubtful debts; and the assessments of whether legacy income should be recognised in the financial statements.

The trustees have also estimated future income and expenditure flows for the purpose of assessing going concern (see below).

Assessment of going concern

The trustees have assessed whether the use of the going concern assumption is appropriate in preparing these financial statements.

Marillac Neurological Care Centre 23

Principal accounting policies Year ended 31 March 2024

Assessment of going concern (continued)

Whilst accepting that there will be challenges ahead, the trustees have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of Marillac Neurological Care Centre to continue as a going concern. The trustees are of the opinion that Marillac Neurological Care Centre will have sufficient resources to meet its liabilities as they fall due for at least the next twelve months.

Income recognition

Income is recognised in the period in which Marillac Neurological Care Centre is entitled to the income, the amount of income can be measured reliably, and it is probable that the income will be received.

Income comprises donations and legacies, interest receivable, fees and charges for nursing care and other income including DCSVP cross charges, cafeteria income and income from other sources.

Donations and grants are recognised when Marillac Neurological Care Centre has confirmation of both the amount and settlement date. In the event of donations or grants pledged but not received, the amount is accrued for where the receipt is considered probable. In the event that a donation or grant is subject to conditions that require a level of performance before Marillac Neurological Care Centre is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of Marillac Neurological Care Centre and it is probable that those conditions will be fulfilled in the reporting period.

In accordance with the Charities SORP FRS 102 volunteer time is not recognised.

Legacies are included in the statement of financial activities when Marillac Neurological Care Centre is entitled to the legacy, the executors have established that there are sufficient surplus assets in estate to pay the legacy, and any conditions attached to the legacy are within the control of Marillac Neurological Care Centre.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably. This is normally upon notification of the interest paid or payable by the bank.

Income from care fees and related charges is recognised to the extent that it is probable that the economic benefits will flow to the charity and the revenue can be reliably measured. It is measured at fair value of the consideration received or receivable, excluding discounts, rebates and value added tax from the date on which the charity is entitled to receipt.

Expenditure recognition

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing Marillac Neurological Care Centre to make a payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Marillac Neurological Care Centre 24

Principal accounting policies Year ended 31 March 2024

Expenditure recognition (continued)

All expenditure is accounted for on an accruals basis. Expenditure comprises direct costs and support costs. All expenses, including support costs, are allocated or apportioned to the applicable expenditure headings. All expenditure relates to the cost of charitable activities i.e. the provision of nursing care and related services.

Support and governance costs

Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the Centre it is necessary to provide support in the form of personnel development, financial procedures, provision of office services and equipment and a suitable working environment.

Governance costs comprise the costs involving the public accountability of Marillac Neurological Care Centre (including audit costs) and costs in respect to its compliance with regulation and good practice.

Tangible fixed assets

All assets costing in excess of £1,000 and with an expected useful life exceeding one year are capitalised in these financial statements.

Debtors

Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid. They have been discounted to the present value of the future cash receipt where such discounting is material.

Cash at bank and in hand

Cash at bank and in hand represents such financial statements and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

Marillac Neurological Care Centre 25

Principal accounting policies Year ended 31 March 2024

Creditors and provisions

Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount Marillac Neurological Care Centre anticipates it will pay to settle the debt. They have been discounted to the present value of the future cash payment where such discounting is material.

Fund structure

Restricted funds comprise monies raised for, or their use restricted to, a specific purpose, or contributions subject to donor imposed conditions.

The tangible fixed assets fund comprises the net book value of the Marillac Neurological Care Centre’s tangible fixed assets. The existence of the assets is fundamental to the Centre being able to perform its charitable work and thereby achieve its charitable objectives. The value represented by such assets should not be regarded as realisable.

The general fund comprises those monies which are freely available for application towards achieving the charitable objectives of Marillac Neurological Care Centre and which may be applied at the discretion of the CEO and in consultation with the trustees.

Leased assets

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the statement of financial activities on a straight-line basis over the lease term.

Lease arrangements that transfer substantially all the risks and rewards of ownership to the lessee are treated as finance leases. Assets held under finance leases are capitalised within tangible fixed assets and depreciated over the shorter of the lease term and useful life of the asset. A liability is recognised for the present value of the minimum lease payments within current and long term liabilities as appropriate. Rental payments are apportioned between capital and interest expense.

Pension contributions

Contributions in respect of the defined contribution pension scheme operated by Marillac Neurological Care Centre are charged to the statement of financial activities when they are payable to the scheme. Contributions are restricted to the contributions disclosed in note 7. There were no outstanding contributions at the year end. Marillac Neurological Care Centre has no liability beyond making its contributions and paying across the deductions for the employees’ contributions.

Marillac Neurological Care Centre 26

Notes to the financial statements Year ended 31 March 2024

1 Income from: Donations and Legacies

Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2023
£
Donation from the
Daughters of Charity of St
Vincent de Paul Charitable
Trust
Legacies
Other donations and grants		 —
19,470
244,871		 500,000
—
121,413		 500,000
19,470
366,284		 —
—
13,083		 —
—
70,355		 —
—
83,438
264,341 621,413 885,754 13,083 70,355 83,438

2 Income from: Other sources

Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2023
£
DCSVP cross charges
(note 18)
Cafeteria income
Miscellaneous income		 152,145
29,398
24,025		 —
—
—		 152,145
29,398
24,025		 144,900
21,515
22,059		 —
—
—		 144,900
21,515
22,059
205,568 — 205,568 188,474 — 188,474

3 Expenditure on: Nursing care and related services

Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2023
£
Staff costs (note 7)
Premises
Provisions
Patient welfare
Other expenses
Support costs (note 4)		 5,461,812
948,547
156,196
214,970
208,093
111,289		 36,068
1,697
—
1,742
—
—		 5,497,880
950,244
156,196
216,712
208,093
111,289		 5,005,675
846,510
146,352
227,488
217,212
115,190		 15,785
957
—
102
15,786
—		 5,021,460
847,467
146,352
227,590
232,998
115,190
7,099,907 39,507 7,139,414 6,558,427 32,630 6,591,057

4 Support costs

Support costs
Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2023
£
Staff costs (note 7)
Central administration
Bank charges
Legal and professional fees
Governance costs (note 5)		 20,651
32,770
1,099
42,108
**14,661 **		 —
—
—
—
—		 20,651
32,770
1,099
42,108
**14,661 **		 15,606
31,862
9,257
38,845
19,620		 —
—
—
—
—		 15,606
31,862
9,257
38,845
19,620
111,289 — 111,289 115,190 — 115,190

Marillac Neurological Care Centre 27

Notes to the financial statements Year ended 31 March 2024

5 Governance costs

Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2024
£		 Un-
restricted
funds
£		 Restricted
funds
£		 Total
funds
2023
£
Auditor’s remuneration
14,661 — 14,661 19,620 — 19,620

6 Net income and net movement in funds

This is stated after charging:

Total
funds
2024
£		 Total
funds
2023
£
Staff costs (note 7)
Auditor’s remuneration – inclusive of VAT
. Statutory audit fees
. Tax advisory services fees
Operating lease rentals
Depreciation
Rental charge for land and buildings		 5,518,531
13,950
711
59,409
140,005
80,000		 5,037,066
13,164
6,456
56,688
144,751
76,000

7 Staff costs and trustees’ remuneration

Staff costs and trustees’ remuneration
2024
£		 2023
£
Staff costs during the year were as follows:
Wages and salaries
Redundancy costs
Social security costs
Other pension costs
Agency costs
Staff costs per function were as follows:
Nursing care and related services
Support services		 4,062,482
—
345,305
137,897		 3,704,876
13,998
333,630
112,300
4,545,684
972,847		 4,164,804
872,262
5,518,531 5,037,066
5,497,880
20,651		 5,021,460
15,606
5,518,531 5,037,066

The average number of employees based on head count, analysed by function, was:

2024
No.		 2023
No.
Nursing and care staff
Administration functions		 162
20		 145
16
182 161

Marillac Neurological Care Centre 28

Notes to the financial statements Year ended 31 March 2024

7 Staff costs and trustees’ remuneration (continued)

The number of employees based on full time equivalents, analysed by function, was:

2024
No.		 2023
No.
Nursing and care staff
Administration functions		 109
13		 108
11
122 119
2024
No.		 2023
No.
£60,001 - £70,000
£70,001 - £80,000
£80,001 - £90,000
£100,001 - £110,000
£110,001 - £120,000
£120,001 - £130,000
£170,001 - £180,000		 2
2
—
1
1
—
1		 —
1
1
—
—
1
—

The key management personnel of Marillac Neurological Care Centre in charge of directing and controlling, running and operating the service on a day-to-day basis comprise the trustees and the Senior Management Team. The total remuneration (including taxable benefits and employer's pension contributions) of the key management personnel for the year was £634,256 (2023: £545,756).

None of the trustees of the charity received any remuneration from Marillac Neurological Care Centre in respect of their services as trustees during the year (2023: £nil) although one of the trustees, Dr Michael Apps, was paid £nil (2023: £750) by the charity for his services as a consultant physician. No expenses were reimbursed to the trustees during the year (2023: none).

8 Taxation

Marillac Neurological Care Centre is a registered charity, and therefore is not liable for income tax or corporation tax on income derived from its charitable activities, as it falls within the various exemptions available to registered charities.

Marillac Neurological Care Centre 29

Notes to the financial statements Year ended 31 March 2024

9 Tangible fixed assets

Tangible fixed assets
Building
improvements
£

Furniture
and
equipment
£		 Motor
vehicles
£
9,349
—
—
9,349
9,348
—
—
9,348
1
1		 Total
£
999,235
1,047,358
(109,194)
1,937,399
433,927
140,005
(109,194)
465,738
1,472,661
565,308
Cost or valuation
At 1 April 2023
Additions
Disposals and eliminations
At 31 March 2024
Depreciation
At 1 April 2023
Charge for the year
On disposals and eliminations
At March 2024
Net book values
At 31 March 2024
At 31 March 2023		 730,431
972,804
(31,537)
259,455

74,554
(77,657)
1,671,698
256,352
287,530
84,975
(31,537)
137,049

55,030
(77,657)
340,968
114,422
1,330,730
141,930
442,901
122,406

The freehold land and buildings occupied by Marillac Neurological Care Centre are owned by the Daughters of Charity of St Vincent de Paul Charitable Trust to which rent is paid.

Therefore, no value has been included in these financial statements in respect to the freehold.

Building improvements and other tangible fixed assets are stated at cost.

10 Debtors

Debtors
Fees and charges
Prepayments and accrued income
Other debtors		 2024
£
766,219
49,647
—
815,866		 2023
£
616,120
54,079
274
670,473

11 Creditors: amounts falling due within one year

Creditors: amounts falling due within one year
Expense creditors
Social security and other taxes
Accruals
Fees in advance
Other creditors		 2024
£
112,195
91,397
131,716
22,400
5,133
362,841		 2023
£
96,917
68,027
89,304
22,400
5,440
282,088

Marillac Neurological Care Centre 30

Notes to the financial statements Year ended 31 March 2024

12 Restricted funds

The income funds of Marillac Neurological Care Centre include restricted funds comprising the following unexpended balances of donations to be applied for specific purposes:

At 1
April
2023
£		 Income
£		 Expenditure
£		 Transfers
£		 At 31
March
2024
£
Sensory garden fund
Rehabilitation kitchen fund
Generator fund
St Catherine’s Unit fund
Catherine Nicol award fund
Hardship fund
Mandy Sheridan fund
Hanging baskets fund
Resident activities fund
Electricity Upgrade fund
Other miscellaneous funds		 550
8,000
5,800
378
3,000
374
1,921
6,376
13,521
—
—		 —
—
84,000
—
—
30
240
—
1,075
500,000
36,068		 (550)
—
—
(378)
—
(154)
—
(1,147)
(1,210)
—
(36,068)		 —
—
(89,800)
—
—
—
—
—
(9,111)
(500,000)
—		 —
8,000
—
—
3,000
250
2,161
5,229
4,275
—
—
39,920 621,413 (39,507) (598,911) 22,915
At 1
April
2022
£		 Income
£		 Expenditure
£		 Transfers
£		 At 31
March
2023
£
Sensory garden fund
Rehabilitation kitchen fund
Generator fund
St Catherine’s Unit fund
Catherine Nicol award fund
Hardship fund
Mandy Sheridan fund
Hanging baskets fund
Resident activities fund
Other miscellaneous funds		 550
8,000
—
378
3,000
453
1,681
7,333
—
—		 —
—
25,000
—
—
24
240
—
13,521
31,570		 —
—
—
—
—
(103)
—
(957)
—
(31,570)		 —
—
(19,200)
—
—
—
—
—
—
—		 550
8,000
5,800
378
3,000
374
1,921
6,376
13,521
—
21,395 70,355 (32,630) (19,200) 39,920

The purposes for which each of the restricted funds are held are as follows:

This fund comprised money donated to Marillac Neurological Care Centre to be used for specific expenses in relation to the provision of a generator.

Marillac Neurological Care Centre 31

Notes to the financial statements Year ended 31 March 2024

12 Restricted funds (continued)

This fund comprises money given specifically towards expenditure in relation to St Catherine’s Unit.

This fund comprises money donated to Marillac Neurological Care Centre and interest earned on the fund to be used to award prizes in memory of Catherine Nicol.

This fund comprises money given specifically towards expenditure for residents who do not have their own funds.

This fund comprises money to provide hanging baskets.

This fund comprises money to upgrade the electricity supply.

13 Tangible fixed assets fund

Tangible fixed assets fund
Total
2024
£		 Total
2023
£
At 1 April
Net movement in year
At 31 March		 565,308
907,353		 499,539
65,769
1,472,661 565,308

The tangible fixed assets fund represents the net book value of tangible fixed assets. Such assets are of fundamental importance to Marillac Neurological Care Centre. Without the assets the organisation would be unable to fulfil its charitable aims and objectives. The value of such assets, therefore, would not be easily realisable if needed to meet future contingencies.

Marillac Neurological Care Centre 32

Notes to the financial statements Year ended 31 March 2024

14 Analysis of net assets between funds

Analysis of net assets between funds
General
fund
£		 Tangible
fixed assets
fund
£		 Restricted
funds
£		 Total
2024
£
Fund balances at 31 March 2024
are represented by:
Tangible fixed assets
Current assets
Creditors: amounts falling due within one year
Total net assets		 —
1,887,626
(362,841)		 1,472,661
—
—		 —
22,915
—		 1,472,661
1,910,541
(362,841)
1,524,785 1,472,661 22,915 3,020,361
General
fund
£		 Tangible
fixed assets
fund
£		 Restricted
funds
£		 Total
2023
£
Fund balances at 31 March 2023
are represented by:
Tangible fixed assets
Current assets
Creditors: amounts falling due within one year
Total net assets		 —
1,873,969
(282,088)		 565,308
—
—		 —
39,920
—		 565,308
1,913,889
(282,088)
1,591,881 565,308 39,920 2,197,109

15 Capital commitments

At 31 March 2024, Marillac Neurological Care Centre had £46,454 capital commitments in respect to improvement to premises that had been authorised but not contracted for (2023: £40,000).

16 Leasing commitments

Operating leases

At 31 March 2024, Marillac Neurological Care Centre had the following future minimum commitments under non-cancellable operating leases in respect to equipment and motor vehicles:

2024
£		 2023
£
Amounts falling due:
. Within one year
. After one but within five years
Total		 72,324
136,057		 47,754
114,168
208,381 161,922

Marillac Neurological Care Centre 33

Notes to the financial statements Year ended 31 March 2024

16 Leasing commitments (continued)

Operating leases (continued)

At 31 March 2024, Marillac Neurological Care Centre had the following future minimum commitments under non-cancellable operating leases in respect of rent:

2024
£		 2023
£
Amounts falling due:
. Within one year
. After one but within five years
After 5 years
Total		 83,920
335,680
1,846,240		 80,000
320,000
1,840,000
2,265,840 2,240,000

17 Rental Income

Operating leases – rent receivable

At 31 March 2024, Marillac Neurological Care Centre had the following future minimum receivables under non-cancellable operating leases in respect of rental income.

2024
£		 2023
£
Amounts falling due:
. Within one year
. After one but within five years
After 5 years
Total		 69,391
277,565
832,696		 66,150
264,600
859,950
1,179,653 1,190,700

18 Controlling party and related party transactions

Controlling party

Marillac Neurological Care Centre is a subsidiary of the Daughters of Charity of St Vincent De Paul Services, which prepares group accounts, including Marillac Neurological Care Centre. The Daughters of Charity of St Vincent de Paul Services, a registered charity (Charity Registration Number 1149326) and a company limited by guarantee (Company Registration Number 07638065 (England and Wales)) is considered the ultimate controlling party of Marillac Neurological Care Centre, as it is its sole member. This Control is normally exercised by the appointment of Trustees. Should the subsidiary drift away from its core mission, Daughters of Charity of St Vincent de Paul Services has the power also to remove the Trustees of the subsidiary.

The registered office address of the Daughters of Charity of St Vincent De Paul Services is St Vincent’s Centre, Carlisle Place, London, SW1P 1NL. The group accounts of the Daughters of Charity of St Vincent de Paul Services can be obtained from the registered office address. The principal purposes and activities of the Daughters of Charity of St Vincent de Paul Services are to safeguard and deepen the Vincentian character of, and provide support to, the charities within the group, including Marillac Neurological Care Centre.

Marillac Neurological Care Centre 34

Notes to the financial statements Year ended 31 March 2024

18 Controlling party and related party transactions (continued)

Controlling party (continued)

The Daughters of Charity of St Vincent de Paul Services (the charitable company) is controlled by the Daughters of Charity of St Vincent de Paul, a Roman Catholic religious congregation, by virtue of the fact that members of the Congregation are also members of the charitable company.

Provision of Catering Services

In accordance with formal agreements, MNCC provides catering services to the religious community at Warley and to Seton Care Unit at Warley (a unit specifically for the care of older Sisters). Both are integral parts of the Daughters of Charity of St Vincent de Paul Charitable Trust. The formal agreements stipulate that either party can terminate the agreement with 6 months notice.

Rent of Land and Buildings

The freehold title to the land and buildings occupied by MNCC is owned by the Daughters of Charity of St Vincent de Paul Charitable Trust. The entire site is leased to MNCC for a period of 30 years commencing 31 March 2021. Certain of the buildings covered by this lease provide accommodation for the religious community at Warley and certain of the buildings are used by Seton Care Unit at Warley (a unit specifically for the care of older Sisters). In both cases, the relevant land and buildings are subject to sub-leases covering a period of 20 years commencing on 31 March 2021.

During the year Marillac Neurological Care Centre received a total of £152,145 (2023: £144,900) relating to cross charges with The Daughters of Charity of St Vincent de Paul Charitable Trust. This consisted of two elements – a rental charge for the use of the land and buildings (£66,150) and a charge for the provision of catering facilities (£85,995).

During the year Marillac Neurological Care Centre paid £80,000 (2023: £76,000) to the Daughters of Charity of St Vincent de Paul Charitable Trust in respect of a rental charge for the use of the land and buildings.

Transactions with trustees

A trustee of the charity, Dr Michael Apps, was paid £0 (2023: £750) by Marillac Neurological Care Centre for his services as a consultant physician.

Other related party transactions

Other than those noted above and in note 7 to these financial statements, there were no other related party transactions requiring disclosure (2023: none).

19 Custodian funds

As at 31 March 2024 Marillac Neurological Care Centre held funds on behalf of residents totalling £7,109 (2023: £12,636) as Custodian Trustee. The funds are held in a bank account separate from the funds of Marillac Neurological Care Centre. The funds are not included in these financial statements and they are segregated clearly from those belonging to Marillac Neurological Care Centre itself at all times.

Marillac Neurological Care Centre 35